Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron ...

Regeneron Pharmaceuticals’ first-in-class investigational allergen-blocking monoclonal antibodies (mAbs) met their primary ...

Regeneron’s Phase III trials show promising results for new antibody treatments, offering rapid and lasting relief from cat ...

The post Her Allergic Neighbor Wants Her Cat Out Of The Hallway, But They Live In A Pet-Friendly Building first on TwistedSifter. Sometimes, being a good neighbor and making your pet happy at the same ...

Regeneron’s allergen-blocking antibodies have reduced the symptoms of cat and pollen allergies in a pair of phase 3 studies.

Regeneron’s antibody duos significantly lowered eye itching and redness, as well as pin prick reactivity, in people with cat ...

Cat allergy is one of the most common indoor allergens, affecting more than 20 million patients in the U.S. alone ...

Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that its experimental therapy significantly reduced symptoms of cat and ...

Regeneron Pharmaceuticals just announced promising results from their Phase 3 study on allergen-blocking antibodies, ...

A nasal allergy test showed strong diagnostic performance, with sensitivity exceeding 75% and specificity approaching 90% for ...

A book club meets a cat cafe at Long Beach's Cool Cat Collective, a gallery and boutique committed to fighting cat ...